Literature DB >> 31708017

Use of phage therapy to treat long-standing, persistent, or chronic bacterial infections.

Stephen T Abedon1.   

Abstract

Viruses of bacteria - known as bacteriophages or phages - have been used clinically as antibacterial agents for nearly 100 years. Often this phage therapy is of long-standing, persistent, or chronic bacterial infections, and this can be particularly so given prior but insufficiently effective infection treatment using standard antibiotics. Such infections, in turn, often have a biofilm component. Phages in modern medicine thus are envisaged to serve especially as anti-biofilm/anti-persistent infection agents. Here I review the English-language literature concerning in vivo experimental and clinical phage treatment of longer-lived bacterial infections. Overall, published data appears to be supportive of a relatively high potential for phages to cure infections which are long standing and which otherwise have resisted treatment with antibieiotics.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Animal models; Antibiotic resistance; Bacteriophage; Bacteriophage therapy; Biofilm; Clinical treatment

Mesh:

Year:  2018        PMID: 31708017     DOI: 10.1016/j.addr.2018.06.018

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  18 in total

Review 1.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

2.  Analysis of Four New Enterococcus faecalis Phages and Modeling of a Hyaluronidase Catalytic Domain from Saphexavirus.

Authors:  Gustavo Di Lallo; Mattia Falconi; Federico Iacovelli; Domenico Frezza; Pietro D'Addabbo
Journal:  Phage (New Rochelle)       Date:  2021-09-17

3.  Pathways to Phage Therapy Enlightenment, or Why I Have Become a Scientific Curmudgeon.

Authors:  Stephen T Abedon
Journal:  Phage (New Rochelle)       Date:  2022-06-16

Review 4.  Biological foundations of successful bacteriophage therapy.

Authors:  Carola Venturini; Aleksandra Petrovic Fabijan; Alicia Fajardo Lubian; Stefanie Barbirz; Jonathan Iredell
Journal:  EMBO Mol Med       Date:  2022-05-27       Impact factor: 14.260

5.  Effect of thermophilic bacterium HB27 manganese superoxide dismutase in a rat model of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).

Authors:  Nai-Wen Chen; Jing Jin; Hong Xu; Xue-Cheng Wei; Ling-Feng Wu; Wen-Hua Xie; Yu-Xiang Cheng; Yi He; Jin-Lai Gao
Journal:  Asian J Androl       Date:  2022 May-Jun       Impact factor: 3.054

Review 6.  Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy?

Authors:  Stephen T Abedon
Journal:  Antibiotics (Basel)       Date:  2019-10-11

7.  Promises and Pitfalls of In Vivo Evolution to Improve Phage Therapy.

Authors:  James J Bull; Bruce R Levin; Ian J Molineux
Journal:  Viruses       Date:  2019-11-21       Impact factor: 5.048

Review 8.  Bacteriophages of Helicobacter pylori.

Authors:  Angela B Muñoz; Johanna Stepanian; Alba Alicia Trespalacios; Filipa F Vale
Journal:  Front Microbiol       Date:  2020-11-12       Impact factor: 5.640

9.  Identification of mycobacteriophage toxic genes reveals new features of mycobacterial physiology and morphology.

Authors:  Ching-Chung Ko; Graham F Hatfull
Journal:  Sci Rep       Date:  2020-09-04       Impact factor: 4.379

Review 10.  Animal Models to Translate Phage Therapy to Human Medicine.

Authors:  Alessia Brix; Marco Cafora; Massimo Aureli; Anna Pistocchi
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.